Condition 1: Cardiovascular diseases. Condition 2: cardiovascular diseases. Atherosclerosis Pure hypercholesterolaemia
Conditions
Interventions
Control group:Control group will take levostatin+ placebo, that patients will take 20mg levostatin with diner+ 8 empty capsule as placebo per day with lunch for 5 months
Intervention 1: intervention group: Intervention group will take levostatin+ Descurainia sophia, that patients will take 20mg levostatin with diner+8 grams of Descurainia Sophia in 8 capsule per day w
Treatment - Drugs
intervention group: Intervention group will take levostatin+ Descurainia sophia, that patients will take 20mg levostatin with diner+8 grams of Descurainia Sophia in 8 capsule per day with lunch for 5
Sponsors
Vice Chancellor for research of Lorestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: cardiovascular patients; aged between 40 to 70 years; LDL cholesterol more than 160 miligram/dl Exclusion criteria: taking anti - lipids, steroids or statins; suffering from diabetes, hypothyroids and nephritic syndrome
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in LDL cholesterol. Timepoint: Before intervention and 5 months after intervention. Method of measurement: With Liberman- Buchard method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mahnaz Mardani
Lorestan University of Medical Sciences
Outcome results
None listed